Efficacy of a tobacco quitline among adult cancer survivors

Robert Klesges, Rebecca Krukowski, James L. Klosky, Wei Liu, Deo Kumar Srivastava, James M. Boyett, Jennifer Q. Lanctot, Melissa M. Hudson, Charla Folsom, Harry Lando, Leslie L. Robison

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The purpose of the study (conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes. Method: Adult onset cancer survivors in Memphis, Tennessee (n. =. 427, 67% female, 60% Caucasian) were randomized either to a Proactive (i.e., counselor-initiated calls) or Reactive (i.e., participant-initiated calls) quitline. Both conditions also received nicotine replacement therapy. The primary outcome was biochemically-verified (i.e., salivary cotinine) smoking cessation. Results: While 12-month self-reported abstinence was consistent with other published studies of smoking cessation (22% and 26% point prevalence abstinence for Proactive and Reactive conditions, respectively), 48% of participants who were tested for cotinine failed biochemical verification, indicating a considerable falsification of self-reported cessation. Adjusted cessation rates were less than 5% in both intervention conditions. Conclusion: Our results are consistent with other studies indicating that traditional smoking cessation interventions are ineffective among cancer survivors. Moreover, self-reports of cessation were unreliable in cancer survivors participating in a quitline intervention, indicating that future studies should include biochemical verification. Given the importance of smoking cessation among cancer survivors and low cessation rates in the current study, it may be necessary to design alternative interventions for this population.

Original languageEnglish (US)
Pages (from-to)22-27
Number of pages6
JournalPreventive Medicine
Volume73
DOIs
StatePublished - Apr 1 2015

Fingerprint

Tobacco
Survivors
Smoking Cessation
Cotinine
Neoplasms
Nicotine
Tobacco Products
Self Report
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Klesges, R., Krukowski, R., Klosky, J. L., Liu, W., Srivastava, D. K., Boyett, J. M., ... Robison, L. L. (2015). Efficacy of a tobacco quitline among adult cancer survivors. Preventive Medicine, 73, 22-27. https://doi.org/10.1016/j.ypmed.2014.12.019

Efficacy of a tobacco quitline among adult cancer survivors. / Klesges, Robert; Krukowski, Rebecca; Klosky, James L.; Liu, Wei; Srivastava, Deo Kumar; Boyett, James M.; Lanctot, Jennifer Q.; Hudson, Melissa M.; Folsom, Charla; Lando, Harry; Robison, Leslie L.

In: Preventive Medicine, Vol. 73, 01.04.2015, p. 22-27.

Research output: Contribution to journalArticle

Klesges, R, Krukowski, R, Klosky, JL, Liu, W, Srivastava, DK, Boyett, JM, Lanctot, JQ, Hudson, MM, Folsom, C, Lando, H & Robison, LL 2015, 'Efficacy of a tobacco quitline among adult cancer survivors', Preventive Medicine, vol. 73, pp. 22-27. https://doi.org/10.1016/j.ypmed.2014.12.019
Klesges, Robert ; Krukowski, Rebecca ; Klosky, James L. ; Liu, Wei ; Srivastava, Deo Kumar ; Boyett, James M. ; Lanctot, Jennifer Q. ; Hudson, Melissa M. ; Folsom, Charla ; Lando, Harry ; Robison, Leslie L. / Efficacy of a tobacco quitline among adult cancer survivors. In: Preventive Medicine. 2015 ; Vol. 73. pp. 22-27.
@article{e04f5a8f63dc4b768255bdd1cc11c43c,
title = "Efficacy of a tobacco quitline among adult cancer survivors",
abstract = "Objective: The purpose of the study (conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes. Method: Adult onset cancer survivors in Memphis, Tennessee (n. =. 427, 67{\%} female, 60{\%} Caucasian) were randomized either to a Proactive (i.e., counselor-initiated calls) or Reactive (i.e., participant-initiated calls) quitline. Both conditions also received nicotine replacement therapy. The primary outcome was biochemically-verified (i.e., salivary cotinine) smoking cessation. Results: While 12-month self-reported abstinence was consistent with other published studies of smoking cessation (22{\%} and 26{\%} point prevalence abstinence for Proactive and Reactive conditions, respectively), 48{\%} of participants who were tested for cotinine failed biochemical verification, indicating a considerable falsification of self-reported cessation. Adjusted cessation rates were less than 5{\%} in both intervention conditions. Conclusion: Our results are consistent with other studies indicating that traditional smoking cessation interventions are ineffective among cancer survivors. Moreover, self-reports of cessation were unreliable in cancer survivors participating in a quitline intervention, indicating that future studies should include biochemical verification. Given the importance of smoking cessation among cancer survivors and low cessation rates in the current study, it may be necessary to design alternative interventions for this population.",
author = "Robert Klesges and Rebecca Krukowski and Klosky, {James L.} and Wei Liu and Srivastava, {Deo Kumar} and Boyett, {James M.} and Lanctot, {Jennifer Q.} and Hudson, {Melissa M.} and Charla Folsom and Harry Lando and Robison, {Leslie L.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.ypmed.2014.12.019",
language = "English (US)",
volume = "73",
pages = "22--27",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Efficacy of a tobacco quitline among adult cancer survivors

AU - Klesges, Robert

AU - Krukowski, Rebecca

AU - Klosky, James L.

AU - Liu, Wei

AU - Srivastava, Deo Kumar

AU - Boyett, James M.

AU - Lanctot, Jennifer Q.

AU - Hudson, Melissa M.

AU - Folsom, Charla

AU - Lando, Harry

AU - Robison, Leslie L.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Objective: The purpose of the study (conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes. Method: Adult onset cancer survivors in Memphis, Tennessee (n. =. 427, 67% female, 60% Caucasian) were randomized either to a Proactive (i.e., counselor-initiated calls) or Reactive (i.e., participant-initiated calls) quitline. Both conditions also received nicotine replacement therapy. The primary outcome was biochemically-verified (i.e., salivary cotinine) smoking cessation. Results: While 12-month self-reported abstinence was consistent with other published studies of smoking cessation (22% and 26% point prevalence abstinence for Proactive and Reactive conditions, respectively), 48% of participants who were tested for cotinine failed biochemical verification, indicating a considerable falsification of self-reported cessation. Adjusted cessation rates were less than 5% in both intervention conditions. Conclusion: Our results are consistent with other studies indicating that traditional smoking cessation interventions are ineffective among cancer survivors. Moreover, self-reports of cessation were unreliable in cancer survivors participating in a quitline intervention, indicating that future studies should include biochemical verification. Given the importance of smoking cessation among cancer survivors and low cessation rates in the current study, it may be necessary to design alternative interventions for this population.

AB - Objective: The purpose of the study (conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes. Method: Adult onset cancer survivors in Memphis, Tennessee (n. =. 427, 67% female, 60% Caucasian) were randomized either to a Proactive (i.e., counselor-initiated calls) or Reactive (i.e., participant-initiated calls) quitline. Both conditions also received nicotine replacement therapy. The primary outcome was biochemically-verified (i.e., salivary cotinine) smoking cessation. Results: While 12-month self-reported abstinence was consistent with other published studies of smoking cessation (22% and 26% point prevalence abstinence for Proactive and Reactive conditions, respectively), 48% of participants who were tested for cotinine failed biochemical verification, indicating a considerable falsification of self-reported cessation. Adjusted cessation rates were less than 5% in both intervention conditions. Conclusion: Our results are consistent with other studies indicating that traditional smoking cessation interventions are ineffective among cancer survivors. Moreover, self-reports of cessation were unreliable in cancer survivors participating in a quitline intervention, indicating that future studies should include biochemical verification. Given the importance of smoking cessation among cancer survivors and low cessation rates in the current study, it may be necessary to design alternative interventions for this population.

UR - http://www.scopus.com/inward/record.url?scp=84921859494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921859494&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2014.12.019

DO - 10.1016/j.ypmed.2014.12.019

M3 - Article

VL - 73

SP - 22

EP - 27

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -